ArticleScience translational medicine2025

A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis.

Shawn C Chafe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.